Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MITAPIVAT vs MOCLOBEMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MITAPIVAT vs MOCLOBEMIDE: Safety Overview

Metric MITAPIVAT MOCLOBEMIDE
Total FAERS Reports 627 461
Deaths Reported 4 76
Death Rate 0.6% 16.5%
Hospitalizations 58 133
Average Patient Age 46.6 yrs 52.0 yrs
% Female Patients 53.5% 48.7%
FDA Approval Date Dec 23, 2025 N/A
Manufacturer Agios Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A